Please use this identifier to cite or link to this item: https://gnanaganga.inflibnet.ac.in:8443/jspui/handle/123456789/10618
Full metadata record
DC FieldValueLanguage
dc.contributor.authorAnij K. Sharma-
dc.contributor.authorBhawna Nishal-
dc.date.accessioned2024-02-27T07:30:52Z-
dc.date.available2024-02-27T07:30:52Z-
dc.date.issued2011-
dc.identifier.urihttp://gnanaganga.inflibnet.ac.in:8080/jspui/handle/123456789/10618-
dc.description.abstractNew drug discovery against variety ofinfections is a major challenge to sc ientific community. Enumerable numbers of antib iotics have been known to be produced by actinomycetes, still the existence of multi-drug resistant microbial strains along with the increase in opportunistic infections in the immune-compromised host and pose a major threat to human life. The need for new, safe and more effective broad spectrum antibiotic is the key to all the above questions. In the recent years, we have seen a surge of actinomycetes producing number of bioactive secondary metabolites. The majority of these compounds have demonstrated one or more bioactivities with many being developed into drugs for treatment of wide range of diseases in humans and other sectors. Considering the immense potential of these actinomycetes in the discovery of lead compounds, current review will discuss about the diverse roles of actinomycetes especially in context of the mechanism pertaining to human health and disease.-
dc.publisherCurrent Trends In Biotechnology and Chemical Research-
dc.titleActinomycetes Implications in Health and Disease-
dc.volVol 1-
dc.issuedNo 2-
Appears in Collections:Articles to be qced



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.